larotrectinib
Selected indexed studies
- Larotrectinib. (, 2006) [PMID:36780411]
- Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. (N Engl J Med, 2018) [PMID:29466156]
- Larotrectinib for solid tumours. (Aust Prescr, 2022) [PMID:35755993]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Larotrectinib. (2006) pubmed
- Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. (2018) pubmed
- Larotrectinib for solid tumours. (2022) pubmed
- Larotrectinib: First Global Approval. (2019) pubmed
- Larotrectinib. (2012) pubmed
- Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials. (2020) pubmed
- Larotrectinib (LOXO-101). (2018) pubmed
- Larotrectinib: A Targeted Therapy for Solid Tumors. (2021) pubmed
- PMID:40854057 (2020) pubmed
- Larotrectinib for the treatment of TRK fusion solid tumors. (2019) pubmed